Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001190137 | SCV001357556 | uncertain significance | Familial hypercholesterolemia | 2019-03-11 | criteria provided, single submitter | clinical testing | Variant of Uncertain Significance due to insufficient evidence: This variant deletes 1 nucleotide in the last exon 12 of the PCSK9 gene, creating a frameshift. This results in the addition of 111 new amino acids before introducing a translation stop codon. To our knowledge, functional assays have not been performed for this variant nor has this variant been reported in individuals affected with familial hypercholesterolemia in the literature. This variant has been identified in 1/249542 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the role of this variant in disease conclusively. |
Fulgent Genetics, |
RCV002491569 | SCV002775170 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV002491569 | SCV004846318 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2023-05-31 | criteria provided, single submitter | clinical testing | This variant deletes 1 nucleotide in exon 12 of the PCSK9 gene, causing a frameshift in the last exon and addition of 130 new amino acids before introducing a stop codon. This results in a protein product that is 111 amino acids longer than the normal protein product. To our knowledge, functional studies have not been reported for this variant. To our knowledge, this variant has not been reported in individuals affected with PCSK9-related disorders in the literature. This variant has been identified in 1/249542 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |